Venture Life Group plc Stock

Equities

VLG

GB00BFPM8908

Pharmaceuticals

Market Closed - London S.E. 11:35:01 2024-06-25 EDT 5-day change 1st Jan Change
49 GBX +1.03% Intraday chart for Venture Life Group plc +18.07% +46.27%

Financials

Sales 2024 * 55.02M 69.76M 95.34M Sales 2025 * 59.42M 75.34M 103M Capitalization 62.06M 78.69M 108M
Net income 2024 * 2M 2.54M 3.47M Net income 2025 * 4M 5.07M 6.93M EV / Sales 2024 * 1.29 x
Net Debt 2024 * 9.17M 11.63M 15.89M Net Debt 2025 * 1.89M 2.4M 3.27M EV / Sales 2025 * 1.08 x
P/E ratio 2024 *
26.6 x
P/E ratio 2025 *
14.8 x
Employees 165
Yield 2024 *
-
Yield 2025 *
-
Free-Float 79.47%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.03%
1 week+18.07%
Current month+20.25%
1 month+25.64%
3 months+32.43%
6 months+44.12%
Current year+46.27%
More quotes
1 week
42.00
Extreme 42
50.00
1 month
38.60
Extreme 38.6
50.00
Current year
32.30
Extreme 32.3
50.00
1 year
27.00
Extreme 27
50.00
3 years
23.00
Extreme 23
102.00
5 years
20.00
Extreme 20
118.00
10 years
20.00
Extreme 20
118.00
More quotes
Managers TitleAgeSince
Founder 60 05-12-11
Director of Finance/CFO 37 21-11-30
Director/Board Member - 14-03-23
Members of the board TitleAgeSince
Founder 60 05-12-11
Director/Board Member 60 22-10-09
Director/Board Member - 14-03-23
More insiders
Date Price Change Volume
24-06-25 49 +1.03% 498,894
24-06-24 48.5 +8.38% 978,033
24-06-21 44.75 +4.07% 325,681
24-06-20 43 0.00% 81,166
24-06-19 43 +3.61% 152,228

Delayed Quote London S.E., June 25, 2024 at 11:35 am

More quotes
Venture Life Group PLC is a United Kingdom-based consumer self-care company. The principal activities of the Company are the development, manufacturing, and commercialization of healthcare products, including medical devices, food supplements and cosmetics for the ageing population. The Company's product portfolio includes products, such as the UltraDEX and Dentyl oral care product ranges; the Balance Activ range in the area of women's intimate healthcare; the Lift Glucose and Glucogel product ranges for hypoglycaemia; Gelclair, Xonrid, and Pomi-T for oncology support products provide symptomatic relief for some of the side effects associated with cancer and its treatment; the Procto-eze Plus product ranges for hemorrhoids, and other Dermatology products. The Company operates through two segments: Venture Life Brands and Customer Brands. The Company's subsidiaries include Venture Life Limited, Lubatti Limited, Periproducts Limited, HL Healthcare Ltd, and Venture Life Healthcare Ltd.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Annual profits - Rate of surprise